Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells

Journal of the National Cancer Institute

Volumn 91, Issue 1, 1999, Pages 37-45

  Cuthbert, Andrew P ^a   Bond, Jacquelyn ^a   Trott, Deborah A ^a   Gill, Sandra ^b   Broni, Jessica ^b   Marriott, Alison ^a   Khoudoli, Guennadi ^a   Parkinson, E Kenneth ^c   Cooper, Colin S ^b   Newbold, Robert F ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b Royal Cancer Hospital   (United Kingdom)

^c BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; BREAST CANCER; CANCER INHIBITION; CHROMOSOME 3P; CONTROLLED STUDY; GENE ISOLATION; GENE LOCATION; GENE REPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REPRESSOR GENE;

EID: 0033528093     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.1.37     Document Type: Article

References (57)

1. Newbold RF, Overell RW. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature 1983;304:648-51.
2. Rheinwald JG, Beckett MA. Tumorigenic keratinocyee lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 1981;41:1657-63.
3. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961;25:585-621.
4. Goldstein S. Replicative senescence: the human fibroblast comes of age. Science 1990;249:1129-33.
5. Newbold RF, Overell RW, Connell JR. Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens. Nature 1982;299:633-5.
6. Namba M, Nishitani K, Hyodoh F, Fukushima F, Kimoto T. Neoplastic transformation of human diploid fibroblasts (KMST-6) by treatment with 60Co gamma rays. Int J Cancer 1985;35:275-80.
7. Newbold RF, Cuthbert AP, Themis M, Trott DA, Blair AL, Li W. Cell immortalization as a key, rate-limiting event in malignant transformation: approaches toward a molecular genetic analysis. Toxicol Lett 1993;67: 211-30.
8. Sager R. Genetic suppression of tumor formation. Adv Cancer Res 1985; 44:43-68.
9. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
10. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43(2 Pt 1):405-13.
11. Watson JD. Origin of concatemeric T7 DNA. Nat New Biol 1972;239: 197-201.
12. Markarov VL, Hirose Y, Langmore JP. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 1997;88:657-66.
13. von Zglinicki T, Saretzki G, Docke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 1995;220:186-93.
14. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
15. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991;256:271-82.
16. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997;90: 785-95.
17. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349-52.
18. Holzman D. Geron extends human cell lifespan with telomerase. Genet Eng News 1998;18:1.
19. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997;277:955-9.
20. Harrington L, Zhou W, McPhail T, Oulton R, Yeung DS, Mar V, et al. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 1997;11:3109-15.
21. Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Human Mol Genet 1997;6:2011-9.
22. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, et al. The RNA component of human telomerase. Science 1995;269:1236-41.
23. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinomaderived skin keratinocytes. Proc Natl Acad Sci U S A 1996;93: 6476-81.
24. Greaves M. Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? Trends Genet 1996;12:127-8.
25. Shay JW, Wright WE. The reactivation of telomerase activity in cancer progression. Trends Genet 1996;12:129-31.
26. Cuthbert AP, Trott DA, Ekong RM, Jezzard S, England NL, Themis M, et al. Construction and characterization of a highly stable human:rodent monochromosome hybrid panel for genetic complementation and genome mapping studies. Cytogenet Cell Genet 1995;71:68-76.
27. England NL, Cuthbert AP, Trott DA, Jezzard S, Nobori T, Carson DA, et al. Identification of human tumour suppressor genes by monochromosome transfer: rapid growth-arrest response mapped to 9p21 is mediated solely by the cyclin-D-dependent kinase inhibitor gene, CDKN2A (p16INK4A). Carcinogenesis 1996;17:1567-75.
28. Newbold RF. Genetic control of telomerase and replicative senescence in human and rodent cells. Ciba Found Symp 1997;211:177-97.
29. Band V, Zajchowski D, Swisshelm K, Trask D, Kulesa V, Cohen C, et al. Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res 1990;50:7351-7.
30. Ning Y, Lovell M, Taylor L, Pereira-Smith OM. Isolation of monochromosomal hybrids following fusion of human diploid fibroblast-derived microcells with mouse A9 cells. Cytogenet Cell Genet 1992;60:79-80.
31. Ning Y, Lovell M, Cooley LD, Pereira-Smith OM. "PCR karyotype" of monochromosomal somatic cell hybrids. Genomics 1993;16:758-60.
32. Newbold RF, Cuthbert AP. Mapping human senescence genes using interspecific monochromosome transfer. In: Freshney RI, Freshney MG, editors. Culture of immortalized cells. New York (NY): Wiley-Liss; 1996. p. 53-75.
33. Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995;23:3794-5.
34. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, et al. A comprehensive genetic map of the human genome based on 5264 micro-satellites. Nature 1996;380:152-4.
35. Collins A, Frezal J, Teague J, Morton NE. A metric map of humans: 23,500 loci in 850 bands. Proc Natl Acad Sci U S A 1996;93:14771-5.
36. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York (NY): Cold Spring Harbor Laboratory Press; 1989.
37. Edington KG, Loughran OP, Berry IJ, Parkinson EK. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high-frequency of allele loss. Mol Carcinog 1995;13:254-65.
38. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995;92:9363-7.
39. Starling JA, Maule J, Hastie ND, Allshire RC. Extensive telomere repeat arrays in mouse are hypervariable. Nucleic Acids Res 1990;18:6881-8.
40. de Lange T. Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 1994;91:2882-5.
41. Shay JW, Wright WE, Werbin H. Loss of telomeric DNA during aging may predispose cells to cancer. Int J Oncol 1993;3:559-63.
42. Ohmura H, Tahara H, Suzuki M, Ide T, Shimizu M, Yoshida MA, et al. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 1995;86:899-904.
43. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995;14:4240-8.
44. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 1997;3:1271-4.
45. Kok K, Naylor SL, Buys CH. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 1997;71:27-92.
46. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, et al. The FHIT gene, spanning the chromosome 3pl4.2 fragile site and acid renal carcinoma-associated t(3-8) breakpoint, is abnormal in digestive-tract cancers. Cell 1996;84:587-97.
47. Mao L. Tumor suppressor genes does FHIT fit? [editorial]. J Natl Cancer Inst 1998;90:412-4.
48. Vielen L, Belair CD, Savelieva L, Julicher K, Brocker F, Bardenheuer W, et al. Minimal deletion of 3pl3→14.2 associated with immortalization of human uroepithelial cells. Genes Chromosomes Cancer 1998;21:39-48.
49. Fusenig NE, Boukamp, P. Multiple stages and genetic alterations govern immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol Carcinog. In press 1998.
50. Boukamp P, Stanbridge EJ, Foo DY, Cerutti PA, Fusenig NE. C-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res 1990;50:2840-7.
51. Yamakawa K, Takahashi T, Horio Y, Murata Y, Takahashi E, Hibi K, et al. Frequent homozygous deletions in lung cancer cell lines detected by a DNA marker located at 3p21.3-p22. Oncogene 1993;8:327-30.
52. Roche J, Boldog F, Robinson M, Robinson L, Varella-Garcia M, Swanton M, et al. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene 1996;12:1289-97.
53. Murata Y, Tamari M, Takahashi T, Horio Y, Hibi K, Yokoyama S, et al. Characterization of an 800 kb region at 3p22-p21.3 that was homozygously deleted in a lung cancer cell line. Hum Mol Genet 1994;3:1341-14.
54. Todd MC, Xiang RH, Garcia DK, Kerbacher KE, Moore SL, Hensel CH, et al. An 80 kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo. Oncogene 1996;13:2387-96.
55. Eiriksdottir G, Bergthorsson JT, Sigurdsson H, Gudmundsson J, Skirnisdottir S, Egilsson V, et al. Mapping of chromosome 3 alterations in human breast cancer using microsatellite PCR markers: correlation with clinical variables. Int J Oncol 1995;6:369-75.
56. Loughran O, Clark LJ, Bond J, Baker A, Berry IJ, Edington KG, et al. Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene 1997;14: 1955-64.
57. Huxley C. Transfer of YACs to mammalian cells and transgenic mice. In: Setlow JK, editor. Genetic engineering. New York (NY): Plenum Press; 1994. p. 65-91.